QIA (QIA)
0.00
-10.35 (100.00%)
Latest Headlines
QIAGEN releases digital PCR assays for Bundibugyo ebolavirus research
May 28, 2026 4:06 PM - StreetInsider
QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak
May 28, 2026 4:05 PM - BizWire
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
May 20, 2026 4:05 PM - BizWire
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
May 19, 2026 4:05 PM - BizWire
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
May 12, 2026 2:00 AM - BizWire
QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
May 7, 2026 6:00 AM - BizWire
QIAGEN Reports Full Results for Q1 2026
May 6, 2026 4:05 PM - BizWire
QIAGEN lowers 2026 outlook as QuantiFERON immigration testing drops
April 27, 2026 4:16 PM - StreetInsider
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
April 27, 2026 4:16 PM - BizWire
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
April 16, 2026 4:05 PM - BizWire
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
April 14, 2026 4:05 PM - BizWire
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results
March 20, 2026 7:30 AM - BizWire
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
March 19, 2026 4:05 PM - BizWire
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
March 10, 2026 5:05 PM - BizWire
Full Article List
